Latest Articles about ALKS

Pre-Market Earnings Report for May 23, 2013 : TD, RL, HRL, DLTR, AAP, SIG, GME, PDCO, ALKS, BKE, TTC, AINV

NASDAQ.com News — Thu, 23 May 2013 00:00:03 Z

The following companies are expected to report earnings prior to market open on 05/23/2013. Visit our Earnings Calendar for a full list of expected earnings releases. Toronto Dominion Bank (

QIAGEN Downgraded to Strong Sell - Analyst Blog

Zacks Equity Research — Tue, 21 May 2013 22:24:58 Z

Zacks Investment Research downgraded QIAGEN N.V. ( QGEN ) to a Zacks Rank #5 (Strong Sell) on May 16. Why the Downgrade? Earnings momentum for this molecular diagnostics company has

Yet Another Acquisition for Bayer - Analyst Blog

Zacks Equity Research — Tue, 21 May 2013 18:29:31 Z

Bayer ( BAYRY ) recently inked a deal to acquire all shares of Germany-based Steigerwald Arzneimittelwerk GmbH. Steigerwald Arzneimittelwerk is a private pharmaceutical company which

Biogen's Hemophilia BLA Accepted - Analyst Blog

Zacks Equity Research — Mon, 20 May 2013 18:25:38 Z

The US Food and Drug Administration (FDA) recently accepted Biogen Idec's ( BIIB ) Biologics License Application (BLA) for its hemophilia A candidate, Eloctate (recombinant factor VIII Fc

SGEN's Adcetris under FDA Review - Analyst Blog

Zacks Equity Research — Fri, 17 May 2013 00:29:37 Z

Seattle Genetics, Inc. ( SGEN ) recently announced that the US Food and Drug Administration (FDA) has accepted its supplemental biologics license application (sBLA) seeking approval of

Cempra/Toyama Ink Deal - Analyst Blog

Zacks Equity Research — Thu, 16 May 2013 01:29:32 Z

Cempra, Inc. ( CEMP ) recently entered into an exclusive license and development agreement with a Japanese company, Toyama Chemical Co., Ltd., a subsidiary of FUJIFILM Holdings ( FUJIY

Much Awaited Test Launch by Genomic - Analyst Blog

Zacks Equity Research — Wed, 15 May 2013 23:28:47 Z

Recently, Genomic Health Inc. ( GHDX ) made available its lead pipeline candidate Oncotype DX prostate cancer test to physicians and their patients. This comes as a major boost to the

Myriad Soars Higher on Celeb Clout - Analyst Blog

Zacks Equity Research — Wed, 15 May 2013 22:27:06 Z

Shares of Myriad Genetics Inc. ( MYGN ) touched a new 52-week high of $34.70 on Tuesday, May 14, 2013 following news out of Hollywood. Academy Award winning Hollywood star Angelina Jolie

Isis Gets $3.5M Milestone Payment - Analyst Blog

Zacks Equity Research — Wed, 15 May 2013 00:05:59 Z

Isis Pharmaceuticals Inc. ( ISIS ) recently announced that it has received a milestone payment of $3.5 million from its partner, Biogen Idec Inc. ( BIIB ). The milestone payment was

The Week Ahead: Full Slate of Economic Data; Earnings From Cisco, Wal-Mart and Deere

Scott Rubin — Sat, 11 May 2013 05:59:38 Z

A host of economic data is set to be released for the week beginning May 13. Investors will also continue to be focused on corporate earnings reports from a number of leading companies. Heading

BioMarin Widens Loss, Maintains View - Analyst Blog

Zacks Equity Research — Mon, 29 Apr 2013 19:50:23 Z

BioMarin Pharmaceutical Inc. 's ( BMRN ) first quarter 2013 loss of 31 cents per share was wider than the Zacks Consensus Estimate of a loss of 28 cents per share and the year-ago loss of

Illumina Beats on Earnings, Revenue - Analyst Blog

Zacks Equity Research — Tue, 23 Apr 2013 23:11:11 Z

Illumina Inc.'s ( ILMN ) first-quarter 2013 adjusted earnings of 46 cents per share beat the Zacks Consensus Estimate by 21%. Adjusted earnings grew almost 28% over the prior-year quarter

Zacks Rank #1 Addition for Tuesday - Tale of the Tape

Zacks Equity Research — Tue, 23 Apr 2013 17:14:12 Z

Here are 5 stocks added to the Zacks Rank #1 ("strong buy") List today: Alkermes Plc ( ALKS ) Allied World Assurance Co Holdings, AG ( AWH ) American National BankShares

Pipeline Progress at Alkermes - Analyst Blog

Zacks Equity Research — Fri, 19 Apr 2013 02:15:07 Z

Alkermes ( ALKS ) recently announced encouraging top-line data from a phase II study (n=142) on ALKS 5461. The study evaluated the safety and efficacy of ALKS 5461 across two doses for the

Market Wrap for Wednesday, April 17: Stocks Plunge Again Along With Euro

Scott Rubin — Thu, 18 Apr 2013 00:27:17 Z

The U.S. stock market fell sharply on Wednesday as volatility continues to pick up on Wall Street. Concerns over global growth have caused the recent market gyrations that have sent the CBOE